age-related macular degeneration
Image of the Day: Retinal Cell Implant
Image of the Day: Retinal Cell Implant
The Scientist Staff | Apr 17, 2018
For the first time, a transplant of replacement tissue grown from stem cells has been shown to be feasible for patients with macular degeneration.
Vision Restored: The Latest Technologies to Improve Sight
Vision Restored: The Latest Technologies to Improve Sight
Anna Azvolinsky | Apr 10, 2018
Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.  
Gene Therapy for Age-Related Macular Degeneration Safe in Humans
Gene Therapy for Age-Related Macular Degeneration Safe in Humans
Diana Kwon | May 17, 2017
A small Phase 1 clinical trial reports that, even at high doses, the treatment did not lead to adverse reactions.
Women Lose Vision After Stem Cell Treatment
Women Lose Vision After Stem Cell Treatment
Kerry Grens | Mar 17, 2017
The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration. 
Bionic Eye Success
Bionic Eye Success
Jef Akst | Jul 23, 2015
An 80-year-old man with age-related vision loss receives a retinal implant that allows him to see basic shapes.
Eye Stem Cell Therapy Moves Ahead
Eye Stem Cell Therapy Moves Ahead
Kate Yandell | Apr 30, 2015
Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety.
First Ever iPS-Cell Trial a Go
First Ever iPS-Cell Trial a Go
Bob Grant | Jul 22, 2013
The Japanese government will allow a study of stem cell therapy using patients’ own cells, reprogrammed to be stem cells, to treat vision loss.
Eye Trials Give Hope for Stem Cells
Eye Trials Give Hope for Stem Cells
Hannah Waters | Jan 24, 2012
Preliminary data from human embryonic stem cell trials for two degenerative eye disorders are promising, but challenges remain for more complex tissues.
An Eye for Stem Cells
Hannah Waters | Dec 1, 2011
Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.